PRE-EMPTIVE OR PROPHYLACTIC THERAPY FOR REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WHO RECEIVED IMMUNOSUPPRESSIVE OR CYTOTOXIC THERAPY: EVALUATION OF BOTH HBsAg-POSITIVE AND HBsAg-NEGATIVE COHORTS

被引:0
|
作者
Tamori, A. [1 ]
Koike, T. [1 ]
Goto, H. [1 ]
Tada, M. [1 ]
Morikawa, H. [1 ]
Enomoto, M. [1 ]
Nakatani, T. [1 ]
Hino, M. [1 ]
Kawada, N. [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
关键词
D O I
10.1016/S0168-8278(13)60433-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
431
引用
收藏
页码:S176 / S176
页数:1
相关论文
共 50 条
  • [41] HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
    Linda Drößler
    Clara Lehmann
    Karin Töpelt
    Dirk Nierhoff
    Jörg J. Vehreschild
    Jan Rybniker
    Michael Hallek
    Julia Fischer
    Verena Stormberg
    Gerd Fätkenheuer
    Ulrike Wieland
    Norma Jung
    Infection, 2019, 47 : 293 - 300
  • [42] Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis
    Mozessohn, L.
    Chan, K. K. W.
    Feld, J. J.
    Hicks, L. K.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (10) : 842 - 849
  • [43] HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?
    Droessler, Linda
    Lehmann, Clara
    Toepelt, Karin
    Nierhoff, Dirk
    Vehreschild, Joerg J.
    Rybniker, Jan
    Hallek, Michael
    Fischer, Julia
    Stormberg, Verena
    Faetkenheuer, Gerd
    Wieland, Ulrike
    Jung, Norma
    INFECTION, 2019, 47 (02) : 293 - 300
  • [44] Incidence and Risk Factors of Hepatitis B Virus Reactivation in HBsAg-Negative, Anti-Hbc-Positive Kidney Transplant Recipients
    Lee, Hyo Young
    Cho, Eun Ju
    Chung, Sung Won
    Kim, Minseok Albert
    Kim, Sun Woong
    Yoon, Jun Sik
    Chang, Young
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan, Sr.
    HEPATOLOGY, 2018, 68 : 1216A - 1216A
  • [45] Allogeneic Hematopoietic Stem Cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV Therapy
    Hu, Yongxian
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Shi, Jimin
    He, Jingsong
    Zheng, Gaofeng
    Zheng, Weiyan
    Xie, Wanzhuo
    Cai, Zhen
    Huang, He
    BLOOD, 2011, 118 (21) : 850 - 851
  • [46] Viral Factors of Patients with Fulminant Hepatic Failure Due to Hepatitis B Virus Reactivation from HBsAg-negative Status
    Umemura, Takeji
    Ota, Masao
    Katsuyama, Yoshihiko
    Joshita, Satoru
    Kiyosawa, Kendo
    Tanaka, Eiji
    HEPATOLOGY, 2012, 56 : 634A - 635A
  • [47] REACTIVATION OF HEPATITIS-B VIRUS-INFECTION INDUCED BY INTERFERON (IFN) IN HBSAG-POSITIVE, ANTIHCV-POSITIVE PATIENTS
    VILLA, E
    GROTTOLA, A
    TRANDE, P
    SEIUM, Y
    REBECCHI, AM
    DUGANI, A
    MANENTI, F
    LANCET, 1993, 341 (8857): : 1413 - 1413
  • [48] DIAGNOSTIC SIGNIFICANCE OF INTRAHEPATOCELLULAR HEPATITIS-B-SURFACE-ANTIGEN (HBSAG), HEPATITIS-B-CORE-ANTIGEN (HBCAG) AND IGG FOR CLASSIFICATION OF INFLAMMATORY LIVER-DISEASES - (STUDIES ON HBSAG-POSITIVE AND HBSAG-NEGATIVE PATIENTS)
    ARNOLD, W
    MEYERZUMBUSCHENFELDE, KH
    HESS, G
    KNOLLE, J
    KLINISCHE WOCHENSCHRIFT, 1975, 53 (22): : 1069 - 1074
  • [49] Increased Detection of HBV DNA in HBsAg-Positive and HBsAg-Negative South African HIV/AIDS Patients Enrolling for Highly Active Antiretroviral Therapy at a Tertiary Hospital
    Lukhwareni, Azwidowi
    Burnett, Rosemary J.
    Selabe, S. Gloria
    Mzileni, M. Olga
    Mphahlele, M. Jeffrey
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (03) : 406 - 412
  • [50] REACTIVATION OF HEPATITIS B VIRUS ESCAPE MUTANTS IN A HBSAG NEGATIVE, ANTI-HBS POSITIVE PATIENT AFTER RITUXIMAB THERAPY
    Rehman, Fnu Khalil Ur
    Rahman, Mansoor
    Usama, Fatima
    Rasikh, Rohullah
    Hassam, Khawaja
    Danishwar, Mahmood
    Ullah, Mati Dad Ullah
    Lau, Daryl
    GASTROENTEROLOGY, 2024, 166 (05) : S1612 - S1612